How to write a local tolerance report

Does local tolerance require a separate study report?

Local tolerance evidence may be embedded in a general toxicity study; M3(R2) generally prefers that approach for the intended therapeutic route. Identify the actual administration site, formulation, methods and findings and cross-reference the controlled report. An empty standalone heading does not establish that a separate study must be generated.

Before you begin

Local-tolerance evidence from standalone studies or an appropriate component of another study. This guide does not mandate a separate experiment.

What you will prepare: A localized-effects report or cross-referenced report contribution with a clear comparison and bounded conclusion.

Find where the local evidence actually resides

Identify the intended administration site, the formulation tested and the question the local assessment was designed to answer. Local observations may be part of a general-toxicity report rather than a separate document. M3(R2) section 8 addresses local tolerance in that development context; an empty 4.2.3.6 heading is not proof that a new standalone study is needed.

If relevant evidence is embedded, identify the report, methods and result locations clearly. Have the dossier owners decide the appropriate cross-reference. Do not rewrite a separate report from selected findings while omitting the original design and limitations.

Collect procedural and formulation context

As a preparation checklist, obtain the test and control formulations, concentration, volume or other administration measure, technique, schedule, site rotation and observed local findings. Include the observation and tissue-examination methods actually used. Distinguish the marketed or proposed formulation from a research formulation when they differ.

Document whether the procedure itself or its control produced local findings. If a control is missing or not comparable, explain the limitation. Do not assume that a reaction is caused by the active substance merely because it appeared at the administration site, or that the vehicle alone explains it without supporting evidence.

Write the local response as a sequence

Describe onset, site, severity as recorded, duration and any follow-up or microscopic findings. Link macroscopic observations and histopathology to the same animals or specimens where applicable. Keep local tolerability distinct from systemic toxicological conclusions; a limited local reaction assessment does not establish whole-product safety.

When repeated administration is involved, explain whether the report assesses repeated use of one site or different sites. State the actual observation period after the final administration. If the team claims recovery, identify the observations that support it and any endpoints that were not reassessed.

Test the relevance of a changed formulation

Fictional example: local-tolerance evidence comes from a dilute research formulation, but the guide's working report conclusion is copied into a dossier for a different concentration and excipient composition. The reviewer should identify the formulation difference and ask the scientific owner for the relevance or bridging rationale.

Do not change the study's formulation description to match the proposed product. Preserve the historical facts, state the evidence boundary and connect any actual supporting assessment. If the rationale is absent, the applicability remains unresolved; the author can finish describing the study while withholding the broader product conclusion.

Compare the tested administration conditions with the proposed use

Use this editorial comparison when a historical study is cited for a current formulation or presentation. It identifies questions for assessment, not automatic rules requiring new experiments.

For each difference, record the scientist's relevance assessment and supporting evidence. “Same active ingredient” is not a completed explanation for changes in the local formulation or procedure. Equally, a difference does not by itself prove the existing evidence is unusable.

Handoff exercise: an injection-site finding appears in clinical observations, but the pathology appendix uses a different specimen label. Resolve the animal, site and specimen mapping with the study owner before treating the two records as the same lesion. The final report should distinguish linked evidence from observations that cannot be confidently matched.

If evidence resides in a repeat-dose report, cite its methods and result locations together. Keep the local assessment's qualified conclusion in the toxicology summary, with any material formulation-relevance limitation.

Frequently asked questions

Sources and revisions

Requirements, source recommendations and editorial preparation advice have different roles. Review the scope and revision of the source you use.

Related guides